TrialNeuro-oncology2011

A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03.

Fabio M Iwamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.